China Signals Commercial Insurance, Biotech And Foreign-Owned Hospitals As Policy Priorities

New Category C Drug List

Policy plans, goals and actions in 2025
China's 2025 government work report reiterated its focus on commercial insurance for innovative drugs, biotech and wholly foreign-owned hospitals. (Shutterstock)

More from China

More from Pink Sheet